Daily non-political popular news in brief.
Novel 3-D cell culture model shows selective tumor uptake of nanoparticles
08-23-2007 · EurekAlert!A novel cell culture model consisting of an aggregate of brain tumor cells growing on normal thin slices of brain tissue has been developed to investigate tumor properties and therapy. The tumor cells showed a similar invasion pattern to that seen when growing in patients. When nanoparticles made from a new type of polymer were added to the co-culture, the nanoparticles were taken up more by the tumor cells than the normal brain cells.
Read more »
Keywords: novel, 3-d, cell, culture, model, shows, selective, tumor, uptake, nanoparticles, show, nanoparticle
« Previous | Next »
Similar news on "Novel 3-D cell culture model shows selective tumor uptake of nanoparticles":
- Novel 3-D cell culture model shows selective tumour uptake of nanoparticles
08-31-2007 · EurekAlert!
A nanoparticle drug delivery system designed for brain tumour therapy has shown promising tumour cell selectivity in a novel cell culture model devised by scientists at The University of Nottingham. The project, conducted jointly by the Schools of Pharmacy, Biomedical Sciences and Human Development, will be featured in the September issue of the Experimental Biology and Medicine.
Similar news · Read more »
- Penn study points to new direction for pancreas cell regeneration
04-03-2007 · EurekAlert!
Past studies in tissue culture have suggested that one type of pancreas cell could be coaxed to transform into insulin-producing islet cells. Now, researchers at the University of Pennsylvania School of Medicine have demonstrated that these pancreatic acinar cells do not become insulin-producing cells in an animal model. However, they did show that injured pancreatic cells readily regenerate back into healthy acinar cells, which has implications for treating cancer and inflammation of the pancreas.
Similar news · Read more »
- Novel MS drug shows promise in 2 lethal leukemias
08-28-2007 · EurekAlert!
A new study suggests that an experimental drug being tested for the treatment of multiple sclerosis and to prevent organ rejection might also help people with certain deadly forms of chronic and acute leukemia. The laboratory and animal study focused on the drug, called fingolimod. Researchers said it might help patients with advanced chronic myelogenous leukemia or acute lymphocytic leukemia, and whose cancer cells show a particular genetic change called the Philadelphia chromosome.
Similar news · Read more »
- Tissue Geometry Plays Crucial Role In Breast Cell Invasion
10-13-2006 · ScienceDaily
Researchers with the U.S. Department of Energy's Lawrence Berkeley National Laboratory have created a first-of-its-kind model for studying how breast tissue is shaped and structured during development. The model may shed new light on how the misbehavior of only a few cells can facilitate metastatic invasion because it shows that the development of breast tissue, normal or abnormal, is controlled not only by genetics, but also by geometry.
Similar news · Read more »
- Cell signaling in cervical cancer; gene variant impairs glycogen synthesis
01-28-2008 · EurekAlert!
Featured in the upcoming edition of PLoS Medicine are "Mouse model shows the role of cell signaling in growth of cervical cancer" and "Genetic variant impairs glycogen synthesis."
Similar news · Read more »
- Immune cell communication key to hunting viruses, Jefferson immunologists show
10-25-2006 · EurekAlert!
Immunologists have used nanotechnology to create a novel "biosensor" to solve in part a perplexing problem in immunology: how the immune system's killer T-cells hunt down invading viruses. They have found that surprisingly little virus can turn on killer T-cells, thanks to some complicated communication among "antigen presenting" proteins that recognize and attach to the virus, making it visible to the immune system. Presenting proteins cooperate, spreading a signal among receptors and boosting T-cell response.
Similar news · Read more »
- Novel small molecule therapy shows benefit for anemic patients via hydration of red blood cells
02-05-2008 · EurekAlert!
Researchers are identifying innovative therapeutics for sickle cell anemia that focus on specific factors in the disease's progression, such as the important role of hydration of the red blood cells. According to a study prepublished online in Blood, the official journal of the American Society of Hematology, a novel small molecule therapy called senicapoc showed efficacy in maintaining hydration of red blood cells and increasing hemoglobin levels in patients with sickle cell anemia.
Similar news · Read more »
- Penn study suggests new model for testing and discovery of anti-HIV drugs
02-08-2007 · EurekAlert!
Researchers at the University of Pennsylvania School of Medicine are the first to show that a mouse protein, whose human equivalent is related to defense against HIV-1, inhibits the infection and spread of a mouse tumor virus. The study provides a new model for the discovery and evaluation of anti-HIV drugs.
Similar news · Read more »
- Signal protein shows promise for blocking tumor promoters in skin cells
11-03-2006 · EurekAlert!
A protein with the ironic name "Srcasm" can counteract the effects of tumor-promoting molecules in skin cells. Using animal models, the researchers discovered that Srcasm acts like a brake in epithelial cells, preventing uncontrolled cell growth caused by a family of proteins called Src kinases. This finding, published online in the Journal of Biological Chemistry, suggests a target for future gene therapy to treat skin, head, neck, colon and breast cancers.
Similar news · Read more »
- New culture method for hepatitis C virus uses primary hepatocytes and patient serum
01-23-2007 · EurekAlert!
Researchers open the way for improved study of hepatitis C virus by devising a novel virus culture system that allows replication of patient-isolated virus in nontransformed hepatocytes, instead of culture-adapted virus strains in transformed cell lines. The related report by Lбzaro et al, "Hepatitis C virus replication in transfected and serum-infected cultured human fetal hepatocytes," appears in the February issue of the American Journal of Pathology.
Similar news · Read more »
